Splenic volume can be a novel predictive parameter for the prognosis of chronic lymphocytic leukemia?
Song
M-K
MK
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute.
Chung
J-S
JS
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute. Electronic address: Hemon@pusan.ac.kr.
Lee
H-S
HS
Department of Hematology-Oncology School of Medicine, Kosin University Gospel Hospital.
Kim
S-H
SH
Department of Hematology-Oncology, School of Medicine, Dong-A University Medical Center.
Suk-Kim
Departments of Radiology.
Yun
E-Y
EY
Statistics, Pusan National University, Busan, Korea.
Seol
Y-M
YM
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute.
Shin
H-J
HJ
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute.
Choi
Y-J
YJ
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute.
Cho
G-J
GJ
Department of Hematology-Oncology, Busan Cancer Center, Pusan National University Hospital Medical Research Institute.
D014408:Biomarkers, Tumor / Q000032:analysis; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D009929:Organ Size; D011379:Prognosis; D013154:Spleen / Q000000981:diagnostic imaging / Q000473:pathology*; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed
D014408:Biomarkers, Tumor